Clinical trials: IgAN

IgA Nephropathy

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

• Terminated
• Age: 7 to 70 years
• Phase 3
• Results posted

IgA nephropathy (IgAN) is the most common type of glomerulonephritis worldwide. 15-40% of individuals diagnosed with IgAN, including children, will eventually progress to chronic renal insufficiency (CRI) and end stage renal…

Trial name

NCT00318474

Testing

Mycophenolate Mofetil (MMF), ACEi, FOS

Where

United States

Volunteers

184 people

Sponsor

St. Joseph's Hospital and Medical Center, Phoenix